ResearcherUniversity of MichiganActive in the last 2 years
Alnawaz Rehemtulla
Matched on ORCID iD 0000-0001-8291-3978; OpenAlex author ID A5007101278; NIH RePORTER profile ID 1878286. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 24
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 grant · 2024: none · 2025: 1 paper
Papers 5
- Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-24-0210↗
- UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Last author DOI 10.1016/j.tranon.2020.100834↗
- Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-14-2793↗
- A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Co-author DOI 10.1016/j.tranon.2014.07.005↗
- Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-12-0098↗
Grants 1
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Judith S Leopold · 1 shared grant, 2023 · strength 0.77
- Theodore Steven Lawrence · 4 shared papers, 2012–2025 · strength 0.34
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210↗
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834↗
- Paper A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. DOI 10.1016/j.tranon.2014.07.005↗
- Meredith Ann Morgan · 2 shared papers, 2020–2025 · strength 0.28
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210↗
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834↗
- David M. Karnak · 2 shared papers, 2012–2025 · strength 0.21
- Paper Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancrea… DOI 10.1158/1535-7163.mct-24-0210↗
- Paper Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0098↗
- Leslie A. Parsels · 1 shared paper, 2025 · strength 0.18
- Qiang Zhang · 1 shared paper, 2025 · strength 0.18
- Eileen S. Carpenter · 1 shared paper, 2025 · strength 0.18
- Victoria M. Valvo · 1 shared paper, 2025 · strength 0.18
- Vaibhav Sahai · 1 shared paper, 2025 · strength 0.18
- Mats E. Ljungman · 1 shared paper, 2020 · strength 0.09
- Carl G. Engelke · 1 shared paper, 2020 · strength 0.09
- Yajing Liu · 1 shared paper, 2020 · strength 0.09
- Nouri Neamati · 1 shared paper, 2020 · strength 0.09
- Judith S. Sebolt · 2 shared papers, 2012–2015 · strength 0.09
- Paper Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic can… DOI 10.1158/0008-5472.can-14-2793↗
- Paper Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0098↗
- Joseph S. Dosch · 1 shared paper, 2015 · strength 0.06
- Brian Dale Ross · 2 shared papers, 2012–2014 · strength 0.06
- Paper A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. DOI 10.1016/j.tranon.2014.07.005↗
- Paper Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0098↗
- Mary Uan-Sian Feng · 1 shared paper, 2014 · strength 0.03
- Mahmoud M. Al-Hawary · 1 shared paper, 2014 · strength 0.03
- Edgar Ben‐Josef · 1 shared paper, 2014 · strength 0.03
- Diane M. Simeone · 1 shared paper, 2014 · strength 0.03
- Mark M. Zalupski · 1 shared paper, 2014 · strength 0.03
- Michelle Ann Anderson · 1 shared paper, 2014 · strength 0.03
- Kyle Clifford Cuneo · 1 shared paper, 2014 · strength 0.03
- Terence Marques Williams · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.